T Torigoe
About
In The Last Decade
T Torigoe
27 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Molecular Biology 428
- Immunology 312
- Oncology 284
- Epidemiology 250
- Surgery 218
Countries citing papers authored by T Torigoe
This map shows the geographic impact of T Torigoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Torigoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Torigoe more than expected).
Fields of papers citing papers by T Torigoe
This network shows the impact of papers produced by T Torigoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Torigoe. The network helps show where T Torigoe may publish in the future.
Co-authorship network of co-authors of T Torigoe
This figure shows the co-authorship network connecting the top 25 collaborators of T Torigoe. A scholar is included among the top collaborators of T Torigoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Torigoe. T Torigoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 17 | |
| 6 | Characterization of n-butyl alcohol solubilized, breast tumor specific antigens recognized by a human autologous cytotoxic T-cell clone. | 10 |
| 7 | Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies. | 41 |
| 8 | 0 | |
| 9 | [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer]. | 14 |
| 10 | Flow Cytometric Study on Tumor Antigen TA－4 in Uterine Cervical Squamous Cells | 1 |
| 11 | Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation. | 50 |
| 12 | Flow cytometric analysis of tumor antigen TA-4 in cervical squamous cells. | 4 |
| 13 | 93 | |
| 14 | 16 | |
| 15 | 22 | |
| 16 | 4 | |
| 17 | Radioimmunoassay for tumor-antigen of human cervical squamous cell carcinoma. | 32 |
| 18 | 97 | |
| 19 | Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma breakdown → | 549 |
| 20 | Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. [/sup 125/I tracer technique] | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.